Conference call on Interim Report
Invitation to attend XVIVO Perfusion’s conference call regarding the presentation of the interim report January – March 2021. The presentation will be held in English
Time: Wednesday, April 21, 2021 at 2.00 p.m. CET
Information regarding the conference can be found under the following link:
https://onlinexperiences.com/Launch/QReg/ShowUUID=2004FDA6-AE15-4016-8E25-4BF9A3FC2796
Phone numbers to the conference:
Sweden: +46 856642651 PIN: 16950415#
UK: +44 3333000804 PIN: 16950415#
USA: +1 6319131422 PIN: 16950415#
Conference name: XVIVO Perfusion Interim Report Q1, conference ID: EV00122810
Participants from XVIVO Perfusion:
Dag Andersson, CEO
Kristoffer Nordström, CFO
The press release for XVIVO Perfusion’s interim report January – March 2021 will be released on April 21, 2021 at 7:30 a.m. CET.
Before the conference call, slides will be available at the company web page, www.xvivoperfusion.com/corporate/.
April, 2021
Gothenburg
XVIVO Perfusion AB (publ)
For further information, please contact:
Dag Andersson, CEO, +46 76 643 30 31, e-mail: dag.andersson@xvivoperfusion.com
Kristoffer Nordström, CFO, +46 73 519 21 64, e-mail: kristoffer.nordstrom@xvivoperfusion.com
About Us
XVIVO Perfusion AB is a medical technology company which develops solutions and systems for assessing and preserving organs outside the body and for selecting usable organs and maintaining them in optimal condition pending transplantation. The company is headquartered in Gothenburg, Sweden, and has one office in Lund, Sweden, one office in Groningen, the Netherlands and one office in Denver, USA. The XVIVO share is listed on Nasdaq Stockholm and has the ticker symbol XVIVO. More information can be found on the website www.xvivoperfusion.com.
